.
1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 1a in CDCl 3 . Figure S2 . 1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 1b in CDCl 3 . Figure S3 . 1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 1c in CDCl 3 . Figure S4 . 1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 1d in CDCl 3 . Figure S5 . 1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 1e in CDCl 3 .
Figure S6.
1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 1f in CDCl 3 .
Figure S7.
1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 1g in CDCl 3 .
Figure S8.
1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 1h in CDCl 3 .
Figure S9.
1 H (400 MHz) and 13 C (100 MHz) NMR spectra of 2a in CDCl 3 . 141.38, 136.13, 135.84, 133.95, 129.62, 128.80, 128.76, 127.09, 126.05, 122.66, 121.87 145.80, 141.62, 136.97, 135.63, 135.57, 134.51, 132.20, 129.67, 127.26, 127.17, 125.96, 122.57, 121.94, 121.86 75, 145.23, 141.20, 137.84, 136.91, 135.88, 131.89, 130.11, 129.67, 127.32, 126.13, 122.92, 122.61, 122.0 73, 145.30, 141.26, 135.83, 135.27, 132.04, 130.31, 129.66, 129.21, 127.23, 126.09, 122.81, 121.94 64, 145.06, 140.92, 137.22, 135.98, 132.02, 130.47, 130.43, 129.65, 129.44, 127.48, 126.36, 126.32, 126.19, 123.20, 121.97 65, 145.14, 135.95, 135.34, 129.67, 129.43, 127.43, 126.18, 125.85, 125.81, 123.04, 121.98 64, 144.91, 140.73, 136.48, 135.81, 133.78, 128.90, 128.52, 127.86, 126.83, 125.13, 123.16, 122.72, 25.23 73, 145.41, 140.87, 137.56, 135.59, 135.38, 134.18, 132.04, 127.85, 126.98, 126.89, 125.07, 123.38, 122.78, 122.19, 25. 92, 144.64, 140.57, 138.27, 136.77, 135.87, 131.89, 129.88, 127.95, 127.38, 127.10, 125.18, 123.30, 122.85, 122.49, 25.45 90, 144.59, 140.47, 137.72, 135.84, 132.08, 131.50, 131.17, 130.30, 129.27, 127.95, 127.20, 126.05, 125.18, 123.36, 122.83, 25.10 61, 144.99, 142.16, 135.70, 135.02, 134.49, 131.56, 128.67, 128.54, 127.81, 126.78, 125.09, 123.27, 122.77, 24.92 83, 150.33, 146.28, 144.49, 141.56, 136.28, 135.73, 134.82, 134.52, 133.25, 129.51, 128.95, 126.71, 126.15, 125.12, 123.07, 122.25, 121.66 17, 148.06, 138.75, 136.24, 136.02, 135.91, 134.62, 133.48, 131.77, 128.68, 128.14, 126.89, 125.18, 122.11, 121.63, 114.95; M.p. = 236.7-237 
Characterization of the synthesized compounds Quinolin-8-yl benzenesulfonate (1a

2-Methylquinolin-8-yl 3-(trifluoromethyl)benzenesulfonate (2e)
.2.941 7.341 7.344 7.362 7.366 7.401 7.411 7.422 7.432 7.491 7.511 7.530 7.576 7.578 7.594 7.598 7.688 7.709 7.751 7.754 7.772 7.774 8.136 8.140 8.157 8.161 8.770 8.774 8.780 8.4.481 7.385 7.396 7.406 7.416 7.471 7.492 7.539 7.558 7.578 7.685 7.702 7.778 7.798 7.957 7.978 8.146 8.149 8.167 8.170 8.765 8.768 8.775 8.2.598 7.255 7.314 7.334 7.482 7.502 7.521 7.543 7.714 7.732 7.751 7.887 7.906 8.014 8.036 8.7.331 7.341 7.351 7.361 7.381 7.398 7.453 7.464 7.474 7.485 7.563 7.583 7.602 7.942 7.962 8.002 8.014 8.018 8.123 8.143 8.540 8.558 8.727 8.733 8.737 9.139 9.142 9.8.150 8.153 8.171 8.174 8.242 8.264 8.304 8.307 8.324 8.328 8.443 8.445 8.461 8.464 8.919 9.132 9.136 9.142 9.
